Does it make sense to change Leronlimab to Livimmune right before a bunch of papers about Leronlimab are going to be published?

Personally, I think that would be bonkers.

Maybe it'll be the brand name it's sold under a few years from now, but in the short term I doubt it means anything.

I would like to see Cytodyn get a name change.